Abstract:In clinics, the minimally invasive freezing therapy, commonly known as cryosurgery, has been increasingly used for the controlled destruction of tumor tissue. However, there are still many bottlenecks to impede the success of a cryosurgery. One of the most critical factors has been that insufficient or inappropriate freezing will not completely destroy the target tumor tissues, which as a result may lead to tumor regenesis and thus failure of treatment. In addition, the surrounding healthy tissues may suffer from serious freeze injury due to unavoidable release of a large amount of cold from the freezing probe. To resolve these challenges, we recently proposed a new strategy, termed as nano-cryosurgery, to improve freezing efficiency of the conventional cryosurgical procedure. The basic principle of this protocol is to deliver functional suspension of nanoparticles with favorable physical and/or chemical properties into the target tissues, which then serve as adjuvant or drug carrier either to maximize the freezing heat transfer process, regulate freezing scale, modify ice-ball formation orientation or prevent the surrounding healthy tissues from being frozen. In addition, introduction of nanoparticles during cryosurgery could also help better image the edge of a tumor as well as the margin of the iceball. The new therapy raised many critical fundamental as well as practical issues for solving. This review is dedicated to present a comprehensive review on multiscale fundamental phase change heat transfer issues thus involved. Attentions would span from micro-scale heat transfer in cellular scale to tissue level. Some related thermal physical effects of nanoparticles on the freezing process such as ice nucleation enhancement, water transport during freezing of a single cell will be discussed. Cryosurgical thermal management of using nanoparticles to modify thermal properties of the tissue-particle components, regulate the growth orientation and strength of an ice ball, enable a conformal tumor destruction in tissues with or without large blood vessels, etc. will be illustrated. Meanwhile, the fundamental issue for the transport of nanoparticle and its assisted drug delivery will be summarized. Theoretical modeling as well as experimental approaches for studying the micro/nano-scale heat transfer throughout the tissue or cell domain during nano-cryosurgery will be suggested. Some potential applications and possible challenges when nanotechnology meets cryosurgery will be outlined. The nano-cryosurgery is expected to help expand the boundary of the emerging frontier of nano-biomedical engineering.

Fe3O4 nanoparticles and cryoablation enhance ice crystal formation to improve the efficiency of killing breast cancer cells.

Enhanced Killing of HepG2 During Cryosurgery with Fe3O4-nanoparticle Improved Intracellular Ice Formation and Cell Dehydration

Improved Synergetic Therapy Efficiency of Cryoablation and Nanoparticles for MCF-7 Breast Cancer.

Effect of Vascular Network and Nanoparticles on Heat Transfer and Intracellular Ice Formation in Tumor Tissues During Cryosurgery

Nano-Cryosurgery: A Basic Way to Enhance Freezing Treatment of Tumor

IMPROVED FREEZING INJURY OF IN VITRO BRAIN TUMOR CELLS BY USE OF NANOPARTICLE ADJUVANTS

Nanoparticle-Encapsulated Doxorubicin Enhances Cryoablation Of Cancer Stem-Like Cells

A new nano-cryosurgical modality for tumor treatment using biodegradable MgO nanoparticles.

Ultrasound Preprocessing To Improve Nanoparticles' Performance In Enhancing Cryosurgery

3D Modelling on Biodegradable Nanoparticle-Enhanced Cryoablation of Liver Tumor Based on Real Anatomical Model.

Nanocryosurgery and its mechanisms for enhancing freezing efficiency of tumor tissues.

In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy.

Enhancement of Cryosurgery Using Biodegradable MgO Nanoparticles

Intracellular Ice Formation and Growth in MCF-7 Cancer Cells.

Nano-Cryosurgery: Advances And Challenges

Nanoparticle-mediated cryosurgery for tumor therapy.

PD-1 monoclonal antibodies enhance the cryoablation-induced antitumor immune response: a breast cancer murine model research

Research progress on anti-tumor immune effect of cryoablation

Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors

Combined Cryosurgery and Cold-Responsive Drug-Loaded Nanoparticles to Enhance Deep-Lying Tumor Therapy: A Mathematical Model

Cryoablation Inhibits the Recurrence and Progression of Bladder Cancer by Enhancing Tumour-Specific Immunity.